U.S. RESEARCH IN CANCER
ISOTOPES TO BE USED AT OAK RIDGE WASHINGTON, March 15. Selected cancer patients will soon be admitted to a new hospital at the Oak Ridge atomic plant for research with isotopes. Children suffering from leukaemia —cancer of the white blood cells —will receive priority. Dr. Shield Warren, medical director of the United States Atomic Energy Commission, said that patients would be taken to Oak Ridge so that the powers of “short-lived” isotopes could be tested. Many of these isotopes “died” before they could he sent very far. Dr. Warren added that medical science already had proved" the value of radio-active iodine and cobalt in cancer treatment.
Permanent link to this item
https://paperspast.natlib.govt.nz/newspapers/AG19500316.2.45
Bibliographic details
Ashburton Guardian, Volume 70, Issue 129, 16 March 1950, Page 5
Word Count
110U.S. RESEARCH IN CANCER Ashburton Guardian, Volume 70, Issue 129, 16 March 1950, Page 5
Using This Item
Ashburton Guardian Ltd is the copyright owner for the Ashburton Guardian. You can reproduce in-copyright material from this newspaper for non-commercial use under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International licence (CC BY-NC-SA 4.0). This newspaper is not available for commercial use without the consent of Ashburton Guardian Ltd. For advice on reproduction of out-of-copyright material from this newspaper, please refer to the Copyright guide.